306 related articles for article (PubMed ID: 24935269)
1. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
[TBL] [Abstract][Full Text] [Related]
2. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
[TBL] [Abstract][Full Text] [Related]
3. Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis.
Hartmann D; Felix K; Ehmann M; Schnölzer M; Fiedler S; Bogumil R; Büchler M; Friess H
Pancreas; 2007 Nov; 35(4):334-42. PubMed ID: 18090239
[TBL] [Abstract][Full Text] [Related]
4. Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
Xue A; Scarlett CJ; Chung L; Butturini G; Scarpa A; Gandy R; Wilson SR; Baxter RC; Smith RC
Br J Cancer; 2010 Jul; 103(3):391-400. PubMed ID: 20588270
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.
Kelly P; Paulin F; Lamont D; Baker L; Clearly S; Exon D; Thompson A
Br J Cancer; 2012 Feb; 106(5):955-61. PubMed ID: 22294182
[TBL] [Abstract][Full Text] [Related]
6. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
7. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
8. Tissue biomarkers of breast cancer and their association with conventional pathologic features.
Chung L; Shibli S; Moore K; Elder EE; Boyle FM; Marsh DJ; Baxter RC
Br J Cancer; 2013 Feb; 108(2):351-60. PubMed ID: 23299531
[TBL] [Abstract][Full Text] [Related]
9. Detection and identification of potential biomarkers of breast cancer.
Fan Y; Wang J; Yang Y; Liu Q; Fan Y; Yu J; Zheng S; Li M; Wang J
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1243-54. PubMed ID: 20237941
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
12. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
13. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
14. Identification of Apolipoprotein C-I Peptides as a Potential Biomarker and its Biological Roles in Breast Cancer.
Sun Y; Zhang J; Guo F; Zhao W; Zhan Y; Liu C; Fan Y; Wang J
Med Sci Monit; 2016 Apr; 22():1152-60. PubMed ID: 27052600
[TBL] [Abstract][Full Text] [Related]
15. SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers.
Laronga C; Becker S; Watson P; Gregory B; Cazares L; Lynch H; Perry RR; Wright GL; Drake RR; Semmes OJ
Dis Markers; 2003-2004; 19(4-5):229-38. PubMed ID: 15258337
[TBL] [Abstract][Full Text] [Related]
16. SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis.
Cheng L; Zhou L; Tao L; Zhang M; Cui J; Li Y
J Cancer Res Clin Oncol; 2008 Jul; 134(7):769-76. PubMed ID: 18202856
[TBL] [Abstract][Full Text] [Related]
17. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
18. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
[TBL] [Abstract][Full Text] [Related]
19. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
[TBL] [Abstract][Full Text] [Related]
20. An efficient biomarker panel for diagnosis of breast cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry.
Yigitbasi T; Calibasi-Kocal G; Buyukuslu N; Atahan MK; Kupeli H; Yigit S; Tarcan E; Baskin Y
Biomed Rep; 2018 Mar; 8(3):269-274. PubMed ID: 29456844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
